新闻中心

新闻

• 北京义翘神州于1月22日全球首发新冠病毒抗原蛋白。 更多 >>

• 北京义翘神州获得比尔及梅琳达·盖茨基金会的捐赠,用于支持新型冠状病毒胶体金和ELISA诊断试剂核心蛋白和抗体原料的开发和大量生产。 更多 >>

• 北京义翘神州将于4月1日发布全新的病毒抗原产品线, ProVirTM更多 >>

• 义翘神州与Nanommune Inc. 合作开发的蛋白芯片产品SinommuneTM上线。 更多>>

• 义翘神州将为GeoVax独家供应新冠肺炎疫苗开发所需的核心科研试剂。 更多>>

最新研究进展

18th May,2020. Researchers at Humabs Biomed SA and the University of Washington recently published a Nature article demonstrating the cross-neutralization of SARS-CoV-2 (Covid-19) using a monoclonal antibody recognizing three SARS RBD spike protein antigens (cat. numbers 40592-V31H, 40592-V05H and 40150-V08B1) developed at Sino Biological. Click this link to read the article!

13rd May,2020. Researchers at Peking University and Beijing Youan Hospital jointly find a potent neutralizing antibodies against SARS-CoV-2 from convalescent patients identified by high-throughput single-cell sequencing of B cells. Sino Biological provide the the technical assistance on mAbs expression and characterization. Click this link to read the article!

按分子首字母查询